CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

PPIs and Long-Term Risk of Pneumonia in Older Adults

Published: Thu, 20 Sep 2018 12:00:00 EDT
Might long-term use of proton-pump inhibitors increase pneumonia risk in the elderly?
Journal of the American Geriatrics Society

Nontuberculous Mycobacteria in Cystic Fibrosis

Published: Thu, 20 Sep 2018 12:00:00 EDT
In this article, the diagnosis, treatment, and impact of nontuberculous mycobacteria infection among patients with cystic fibrosis is discussed.
Seminars in Respiratory and Critical Care Medicine

Early Life Vitamin D Status and Asthma and Wheeze

Published: Thu, 20 Sep 2018 12:00:00 EDT
A new study examines the possible effects of early life vitamin D levels on the development of asthma or wheeze later in life.
BMC Pulmonary Medicine
Displaying results 16-18 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Genentech antibiotic shows broad activity against multidrug-resistant bugs in mice

Published: Mon, 17 Sep 2018 13:49:47 +0000
Scientists at Genentech have perfected a naturally occurring molecule so it can penetrate E. coli and other Gram-negative bacteria. The discovery could lead to a whole new class of antibiotics.

FDA lifts clinical hold from Mersana’s breast cancer trial

Published: Mon, 17 Sep 2018 12:19:31 +0000
The FDA has lifted the partial clinical hold it placed on a phase 1 trial of Mersana Therapeutics’ HER2-targeted antibody-drug conjugate. Regulatory officials put enrollment in the XMT-1522 breast cancer trial on hold in July after learning of the death of a participant.

Realm surrenders after back-to-back clinical defeats

Published: Mon, 17 Sep 2018 10:39:46 +0000
Faced with a pair of phase 2 failures, Realm Therapeutics has abandoned the platform that underlies all its drug development programs and engaged advisers to look into a possible sale.
Displaying results 16-18 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top